The differential effect of anti-CD40 mAb on cellular and humoral immune responses in wild type and complement deficient mice

被引：0

作者：

Ajona, D. ^{[1
]}

French, R. R. ^{[1
]}

Glennie, M. J. ^{[1
]}

机构：

[1] Univ Southampton, Canc Sci Div, Tenovus Res Lab, Southampton SO9 5NH, Hants, England

来源：

IMMUNOLOGY | 2008年 / 125卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：130 / 130

页数：1

共 50 条

[41] Defective B cell ontogeny and humoral immune response in mice prematurely expressing human complement receptor 2 (CR2, CD21) is similar to that seen in aging wild type mice [J].

Twohig, Jason P. ;

Pappworth, Isabel Y. ;

Sivasankar, Baalasubramanian ;

Kulik, Liudmila ;

Bull, Melanie ;

Holers, V. Michael ;

Wang, Eddie C. Y. ;

Marchbank, Kevin J. .

MOLECULAR IMMUNOLOGY, 2009, 46 (10) :2002-2013

[42] Antibody to CD40 ligand inhibits both humoral and cellular immune responses to adenoviral vectors and facilitates repeated administration to mouse airway [J].

A Scaria ;

JA St George ;

RJ Gregory ;

RJ Noelle ;

SC Wadsworth ;

AE Smith ;

JM Kaplan .

Gene Therapy, 1997, 4 :611-617

[43] Harnessing localized anti-cancer treatments for systemic anti-metastatic tumor responses in aged mice through the combination of local anti-CD40 agonist and cGAMP/irradiation [J].

Yan, Minglu ;

Chen, Zhijian ''James'' .

CANCER IMMUNOLOGY RESEARCH, 2025, 13 (02)

[44] CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge [J].

Gurunathan, S ;

Irvine, KR ;

Wu, CY ;

Cohen, JI ;

Thomas, E ;

Prussin, C ;

Restifo, NP ;

Seder, RA .

JOURNAL OF IMMUNOLOGY, 1998, 161 (09) :4563-4571

[45] Antibody to CD40 ligand inhibits both humoral and cellular immune responses to adenoviral vectors and facilitates repeated administration to mouse airway [J].

Scaria, A ;

StGeorge, JA ;

Gregory, RJ ;

Noelle, RJ ;

Wadsworth, SC ;

Smith, AE ;

Kaplan, JM .

GENE THERAPY, 1997, 4 (06) :611-617

[46] Initiation of humoral and cellular immune responses in patients with refractory Hodgkin's disease by treatment with an anti-CD16/CD30 bispecific antibody [J].

Renner, C ;

Hartmann, F ;

Jung, W ;

Deisting, C ;

Juwana, M ;

Pfreundschuh, M .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 49 (03) :173-180

[47] Initiation of humoral and cellular immune responses in patients with refractory Hodgkin's disease by treatment with an anti-CD16/CD30 bispecific antibody [J].

Christoph Renner ;

Frank Hartmann ;

Wolfram Jung ;

Christina Deisting ;

Marieta Juwana ;

Michael Pfreundschuh .

Cancer Immunology, Immunotherapy, 2000, 49 :173-180

[48] Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and vasculopathy in CD40 ligand-deficient mice [J].

Corbascio, M ;

Mahanty, H ;

Österholm, C ;

Qi, ZQ ;

Pearson, TC ;

Larsen, CP ;

Freise, CE ;

Ekberg, H .

TRANSPLANTATION, 2002, 74 (01) :35-41

[49] Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvants [J].

Revaz, Veronique ;

Zurbriggen, Rinaldo ;

Moser, Christian ;

Schiller, John T. ;

Ponci, Franqoise ;

Bobst, Martine ;

Nardelli-Haefliger, Denise .

ANTIVIRAL RESEARCH, 2007, 76 (01) :75-85

[50] Systemic agonistic anti-CD40 treatment of tumor bearing mice modulates hepatic myeloid suppressive cells and causes immune-mediated liver damage [J].

Medina-Echeverz, Jose ;

Ma, Chi ;

Eggert, Tobias ;

Greten, Tim F. .

CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)

← 1 2 3 4 5 →